Your browser doesn't support javascript.
loading
Evaluation of pharmacogenomics and hepatic nuclear imaging-related covariates by population pharmacokinetic models of irinotecan and its metabolites.
Liu, Zheng; Martin, Jennifer H; Liauw, Winston; McLachlan, Sue-Anne; Link, Emma; Matera, Anetta; Thompson, Michael; Jefford, Michael; Hicks, Rod J; Cullinane, Carleen; Hatzimihalis, Athena; Campbell, Ian; Crowley, Simone; Beale, Phillip J; Karapetis, Christos S; Price, Timothy; Burge, Mathew E; Michael, Michael.
Affiliation
  • Liu Z; School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia.
  • Martin JH; Clinical Pharmacology, Department of Medicine, The Royal Children's Hospital Melbourne, Melbourne, Australia.
  • Liauw W; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia.
  • McLachlan SA; School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia.
  • Link E; Department of Medical Oncology, St. George's Hospital, Sydney, Australia.
  • Matera A; Department of Medical Oncology, St. Vincent's Hospital, Melbourne, Australia.
  • Thompson M; Biostatistics and Clinical Trials Centre, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Jefford M; Department of Oncology, Sir Peter MacCallum, University of Melbourne, Melbourne, Australia.
  • Hicks RJ; Biostatistics and Clinical Trials Centre, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Cullinane C; Department of Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Hatzimihalis A; Department of Oncology, Sir Peter MacCallum, University of Melbourne, Melbourne, Australia.
  • Campbell I; Department of Medical Oncology, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC, 3000, Australia.
  • Crowley S; Department of Oncology, Sir Peter MacCallum, University of Melbourne, Melbourne, Australia.
  • Beale PJ; Department of Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Karapetis CS; Department of Oncology, Sir Peter MacCallum, University of Melbourne, Melbourne, Australia.
  • Price T; Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Burge ME; Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Michael M; Department of Oncology, Sir Peter MacCallum, University of Melbourne, Melbourne, Australia.
Eur J Clin Pharmacol ; 78(1): 53-64, 2022 Jan.
Article in En | MEDLINE | ID: mdl-34480602
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Colorectal Neoplasms / Glucuronosyltransferase / Topoisomerase I Inhibitors / Irinotecan / Liver Type of study: Observational_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Oceania Language: En Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Colorectal Neoplasms / Glucuronosyltransferase / Topoisomerase I Inhibitors / Irinotecan / Liver Type of study: Observational_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Oceania Language: En Year: 2022 Type: Article